$PTOS
P2 Solar, Inc.

2024 Q1 Form 10-Q Financial Statement

#000164033424000238 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $12.05K $22.17K $0.00
YoY Change
Cost Of Revenue $7.930K $23.60K $0.00
YoY Change
Gross Profit $4.120K -$1.435K $0.00
YoY Change
Gross Profit Margin 34.19% -6.47%
Selling, General & Admin $23.85K $44.76K
YoY Change
% of Gross Profit 578.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $23.84K $44.76K $23.76K
YoY Change 88.37%
Operating Profit -$19.72K -$46.19K -$23.76K
YoY Change 94.41%
Interest Expense -$26.76K $8.352K $7.842K
YoY Change 6.5%
% of Operating Profit
Other Income/Expense, Net $0.00 $11.44K -$27.65K
YoY Change -141.38%
Pretax Income -$46.47K -$34.75K
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$46.47K -$34.75K -$51.41K
YoY Change -32.4%
Net Earnings / Revenue -385.64% -156.76%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 67.95M shares 67.95M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $210.00 $260.00
YoY Change
Cash & Equivalents $213.00 $256.00 $5.129K
Short-Term Investments
Other Short-Term Assets $3.900K $4.000K
YoY Change
Inventory
Prepaid Expenses $3.900K $3.995K
Receivables $11.86K $27.57K
Other Receivables $8.390K $8.820K
Total Short-Term Assets $24.36K $40.64K
YoY Change 44.07%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $90.25K $3.168K
YoY Change 2748.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $90.25K $3.168K
YoY Change 2749.83%
TOTAL ASSETS
Total Short-Term Assets $24.36K $40.64K
Total Long-Term Assets $90.25K $3.168K
Total Assets $114.6K $43.81K
YoY Change 470.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $284.5K
YoY Change
Accrued Expenses $293.6K $285.2K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.297M $1.304M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.860M $1.874M
YoY Change 8.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $87.09K
YoY Change
Total Long-Term Liabilities $87.09K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.860M $1.874M
Total Long-Term Liabilities $87.09K $0.00
Total Liabilities $1.947M $1.874M
YoY Change 14.07%
SHAREHOLDERS EQUITY
Retained Earnings -$8.110M -$8.064M
YoY Change 1.86%
Common Stock $67.95K $67.95K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.833M -$1.830M -$1.693M
YoY Change
Total Liabilities & Shareholders Equity $114.6K $43.81K
YoY Change 470.95%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$46.47K -$34.75K -$51.41K
YoY Change -32.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$9.710K -$23.00K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.670K -2.080K
YoY Change
NET CHANGE
Cash From Operating Activities -9.710K -23.00K
Cash From Investing Activities
Cash From Financing Activities -1.670K -2.080K
Net Change In Cash -11.38K -25.08K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$9.710K -$23.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27571 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
8821 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
40643 usd
CY2023Q4 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q4 us-gaap Assets
Assets
43811 usd
CY2023Q1 us-gaap Assets
Assets
20075 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
284518 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
285206 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
472290 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
526339 usd
CY2023Q4 us-gaap Revenues
Revenues
22168 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
23603 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
-1435 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
83170 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
853 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
9251 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
9132 usd
CY2023Q4 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13743 usd
CY2022Q4 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
13775 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
44756 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
23760 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-46191 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
8352 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
7842 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
19796 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19806 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51409 usd
CY2023Q4 us-gaap Profit Loss
ProfitLoss
-34750 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-51409 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40114 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20126 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-74864 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71535 usd
CY2022Q4 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001172069
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-91190
dei Entity Registrant Name
EntityRegistrantName
P2 SOLAR, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0234680
dei Entity Address Address Line1
EntityAddressAddressLine1
13718 91 Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Surrey
dei Entity Address City Or Town
EntityAddressCityOrTown
British Columbia
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V3V 7X1
dei City Area Code
CityAreaCode
778
dei Local Phone Number
LocalPhoneNumber
321-0047
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
67946513 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
256 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3995 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
16907 usd
CY2023Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
83170 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
18473 usd
CY2023Q4 ptos Due To Related Party Current
DueToRelatedPartyCurrent
748908 usd
CY2023Q1 ptos Due To Related Party Current
DueToRelatedPartyCurrent
677962 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1874092 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1707152 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1874092 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1707152 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67946513 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
67947 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
67947 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6542783 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6542783 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8063819 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7961863 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-377192 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-335944 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1830281 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687077 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43811 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20075 usd
us-gaap Revenues
Revenues
154234 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
91386 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Gross Profit
GrossProfit
62848 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21762 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37965 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
944 usd
us-gaap Professional Fees
ProfessionalFees
78467 usd
us-gaap Professional Fees
ProfessionalFees
26652 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
41639 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
42774 usd
us-gaap Operating Expenses
OperatingExpenses
158071 usd
us-gaap Operating Expenses
OperatingExpenses
70370 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-23760 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-95223 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-70370 usd
us-gaap Interest Expense
InterestExpense
24446 usd
us-gaap Interest Expense
InterestExpense
23573 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17073 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-92585 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
640 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11441 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27647 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6733 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-116157 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-34750 usd
us-gaap Net Income Loss
NetIncomeLoss
-101956 usd
us-gaap Net Income Loss
NetIncomeLoss
-186529 usd
us-gaap Profit Loss
ProfitLoss
-101956 usd
us-gaap Profit Loss
ProfitLoss
-186529 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-41248 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
132538 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-143204 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53991 usd
CY2023Q4 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2022Q4 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2023Q4 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1687077 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-37771 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-25766 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1750614 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
36637 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-41440 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1755417 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-40114 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-34750 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1830281 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1639129 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
50163 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-60395 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1649362 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
102501 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-74725 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-1621587 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20126 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51409 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1693122 usd
us-gaap Net Income Loss
NetIncomeLoss
-101956 usd
us-gaap Net Income Loss
NetIncomeLoss
-186529 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27036 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-644 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
110 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3918 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3616 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
58366 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
43330 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
14302 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
42776 usd
ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
41639 usd
ptos Increase Decrease In Management Fees Payables
IncreaseDecreaseInManagementFeesPayables
42774 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17959 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54142 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
57235 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12191 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
44735 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
7308 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
54125 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
63022 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7616 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21397 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12499 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10826 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36515 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7388 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5128 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10257 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
256 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5129 usd
us-gaap Interest Paid Net
InterestPaidNet
3799 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
110000 usd
CY2022Q4 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
0.03
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8063819 usd
us-gaap Net Income Loss
NetIncomeLoss
-101956 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
256 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7644 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
27571 usd
CY2023Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q4 ptos Accounts Receivable Percentage
AccountsReceivablePercentage
0.10 pure
CY2023Q4 us-gaap Other Receivables
OtherReceivables
8821 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9263 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3995 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
284518 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
219896 usd
CY2023Q4 us-gaap Goodwill
Goodwill
3168 usd
us-gaap Revenues
Revenues
154234 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
91386 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Gross Profit
GrossProfit
62848 usd
us-gaap Gross Profit
GrossProfit
0 usd
ptos Total Sales Revenue
TotalSalesRevenue
0.10 pure
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-34750 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-51409 usd
us-gaap Net Income Loss
NetIncomeLoss
-101956 usd
us-gaap Net Income Loss
NetIncomeLoss
-186529 usd
CY2023Q4 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2022Q4 ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
ptos Net Loss Per Share Basic And Diluted
NetLossPerShareBasicAndDiluted
-0.00
CY2023Q4 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
CY2022Q4 ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
ptos Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
67946513 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
3666667 shares
CY2023Q1 ptos Business Acquisitions Purchase Price Estimation
BusinessAcquisitionsPurchasePriceEstimation
0.25 pure
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
0 usd
CY2023Q4 ptos Bank Consideration Paid
BankConsiderationPaid
6 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
6 usd
CY2023Q4 ptos Shareholder Loan Payable
ShareholderLoanPayable
-2196 usd
CY2023Q4 ptos Gst Payable During Acquisition
GstPayableDuringAcquisition
-977 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
3173 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
-3168 usd
CY2023Q4 us-gaap Goodwill
Goodwill
3168 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
472290 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
526339 usd
CY2023Q4 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2023Q1 ptos Less Non Current Portion Of Promissory Note Payable
LessNonCurrentPortionOfPromissoryNotePayable
0 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
472290 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
526339 usd
us-gaap Notes Issued1
NotesIssued1
36331 usd
CY2023Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
18473 usd
CY2023Q4 ptos Noncurrentportionofconvertiblenotepayable
noncurrentportionofconvertiblenotepayable
0 usd
CY2023Q1 ptos Noncurrentportionofconvertiblenotepayable
noncurrentportionofconvertiblenotepayable
0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
83170 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
18473 usd
us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
us-gaap Interest Expense
InterestExpense
24446 usd
us-gaap Interest Expense
InterestExpense
23573 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
285206 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
264482 usd
CY2023Q4 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
748908 usd
CY2023Q1 ptos Accrued Management Salary To Related Party
AccruedManagementSalaryToRelatedParty
676706 usd
CY2023Q4 ptos Due To Related Party Current
DueToRelatedPartyCurrent
748908 usd
CY2023Q1 ptos Due To Related Party Current
DueToRelatedPartyCurrent
677962 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67946513 shares

Files In Submission

Name View Source Status
0001640334-24-000238-index-headers.html Edgar Link pending
0001640334-24-000238-index.html Edgar Link pending
0001640334-24-000238.txt Edgar Link pending
0001640334-24-000238-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ptos-20231231.xsd Edgar Link pending
ptos_10q.htm Edgar Link pending
ptos_ex311.htm Edgar Link pending
ptos_ex312.htm Edgar Link pending
ptos_ex321.htm Edgar Link pending
ptos_ex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ptos-20231231_cal.xml Edgar Link unprocessable
ptos-20231231_def.xml Edgar Link unprocessable
ptos-20231231_lab.xml Edgar Link unprocessable
ptos-20231231_pre.xml Edgar Link unprocessable
ptos_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable